SCHEMBL30112544

SCHEMBL30112544

Cl[Co]Cl.c1ccc(-c2cc(-c3ccccc3)cc(-c3ccc4ccc5cccnc5c4n3)c2)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 3/20 0.47
▸ CCR8 P51685 3/20 0.47
▸ KDM4E B2RXH2 3/20 0.47
▸ CCR5 P51681 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ MAPT P10636 2/20 0.47
▸ GMNN O75496 1/20 0.47
▸ TP53 P04637 1/20 0.47
▸ HSP90AA1 P07900 1/20 0.47
▸ MMP2 P08253 1/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ CYP2D6 P10635 1/20 0.47
▸ MMP9 P14780 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ MMP8 P22894 1/20 0.47
▸ THPO P40225 1/20 0.47
▸ MTOR P42345 1/20 0.47
▸ HTT P42858 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30112679 0.94 KDM4E (0.53) CCR1CCR8KDM4ECCR5LMNA
SCHEMBL17899337 0.87 CCR1 (0.61) CCR1CCR8KDM4ECCR5LMNA
SCHEMBL16852209 0.86 CCR1 (0.52) CCR1CCR8KDM4ECCR5LMNA
SCHEMBL11962211 0.86 CCR1 (0.64) CCR1CCR8KDM4ECCR5LMNA
SCHEMBL19486732 0.86 MAPT (0.44) CCR1CCR8KDM4ECCR5LMNA
SCHEMBL19486694 0.85 TOP1 (0.48) CCR1CCR8KDM4ECCR5LMNA
SCHEMBL17174057 0.84 KDM4E (0.57) CCR1CCR8KDM4ECCR5LMNA
SCHEMBL30449837 0.84 LMNA (0.61) CCR1CCR8KDM4ECCR5LMNA
SCHEMBL1395123 0.84 LMNA (0.61) CCR1CCR8KDM4ECCR5LMNA
SCHEMBL21841075 0.84 TOP1 (0.53) CCR1CCR8KDM4ECCR5LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110028504-B Preparation method and application of 2, 9-diaryl substituted o-phenanthroline and cobalt complex thereof 南开大学(CN) 2023-01-13 — — CN claimed
CN-112805005-B Thyroxine receptor beta agonist compounds 拓臻股份有限公司 2026-05-12 — — CN disclosed
CN-119552115-A Heterocyclic compound and application thereof in medicine 康百达(四川)生物医药科技有限公司 2025-03-04 — — CN disclosed
CN-119285613-A Substituted quinoxaline and quinazolinone compounds and uses thereof 河南中医药大学 2025-01-10 — — CN disclosed
CN-113454097-B Tubulysin and protein-tubulysin conjugates 里珍纳龙药品有限公司 2024-08-30 — — CN disclosed
CN-115843271-B Indole derivatives and their use for the treatment of cancer 克洛德贝纳尔-里昂第一大学 2024-08-13 — — CN disclosed
CN-118055927-A Substituted phenylpropionic acid derivative and application thereof 上海拓界生物医药科技有限公司 2024-05-17 — — CN disclosed
CN-117185987-A Amidine and guanidine derivatives, preparation method and medical application thereof 四川科伦博泰生物医药股份有限公司 2023-12-08 — — CN disclosed
CN-117083274-A Fused ring heterocyclic derivative and application thereof in medicine 四川海思科制药有限公司 2023-11-17 — — CN disclosed
CN-111630048-B Amidine and guanidine derivatives, preparation method and medical application thereof 四川科伦博泰生物医药股份有限公司 2023-09-29 — — CN disclosed
CN-116514817-A Heterocyclic compound with AKT kinase inhibition activity, preparation method and medical application thereof 中国医药研究开发中心有限公司 2023-08-01 — — CN disclosed
CN-112010858-B BTK inhibitor, preparation method and pharmaceutical application thereof 四川海思科制药有限公司 2023-07-18 — — CN disclosed
CN-114717211-B Imine reductase mutant M5 and application thereof in synthesis of nitrogen heterocycle chiral amine 江苏集萃分子工程研究院有限公司 2023-06-02 — — CN disclosed
CN-115843271-A Indole derivatives and their use for the treatment of cancer 克洛德贝纳尔-里昂第一大学 2023-03-24 — — CN disclosed
CN-113121574-B Purine derivatives and their use in medicine 成都百裕制药股份有限公司 2023-02-17 — — CN disclosed
CN-110028504-B Preparation method and application of 2, 9-diaryl substituted o-phenanthroline and cobalt complex thereof 南开大学(CN) 2023-01-13 — — CN disclosed
Send feedback